News for Aurobindo Pharma Limited (AUROPHARMA.BO)

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. Court of Appeals for the Federal Circuit affirmed a decision issued by the U.S. Distri

ANN ARBOR, Mich., June 02, 2025 (GLOBE NEWSWIRE) -- Esperion ( ESPR) today announced that it has entered into a settlement agreement with Hetero USA, Inc. and

The Nifty Pharma index was trading 0.42 per cent down at 21352.55.

The Nifty Pharma index closed 0.68 per cent down at 21442.05.

The Nifty Pharma index was trading 0.64 per cent down at 21451.7.

The Nifty Pharma index closed 0.92 per cent up at 21589.35.

The Nifty Pharma index was trading 0.18 per cent up at 21432.5.

The Nifty Pharma index closed 0.61 per cent down at 21393.3.

Markets close lower as investors brace for futures and options expiry, with sectoral performance mixed and rupee stable.

The Nifty Pharma index closed 0.11 per cent up at 21524.95.

The Nifty Pharma index closed 0.11 per cent up at 21524.95.

"For traders, 24,870/81900 would act as a key support zone. Above this level, bullish sentiment is likely to continue. On the higher side, 25,150–25,250/82500-82800 would act as key resistance areas for traders," said Shrikant Chouhan, head, equity research, Kotak Securities.

Jaiprakash Associates approves Rs 936.27 crore cash outflow; Reliance Defence partners with Rheinmetall AG; LIC sets Guinness World Record.

Movement in the equity market this week will be guided by a host of macroeconomic data announcements, global trends and trading activity of foreign investors, analysts said. Stocks markets concluded the last week on a subdued note, as investors grappled with global uncertainties.

India Business News: Indian equities are poised for a week influenced by domestic macroeconomic data, global cues, and foreign investor activity. Subdued performance in th

Nifty weekly performance: Indian markets ended the week down 0.7%, amid sharp volatility triggered by global bond market jitters. Despite midweek sell-offs, the Nifty rebounded on Friday, led by IT and FMCG stocks. Analysts say strong DII and retail support cushioned the fall. Key upcoming triggers include Indias GDP data, U.S. budget, inflation, and jobless claims.

The Nifty Pharma index closed 0.41 per cent down at 21434.25.

The Indian pharmaceutical sector is poised for significant growth, driven by favorable trade agreements and increasing global demand for generic medicines. This article delves into the sector's performance, outlook, and highlights key companies with promising upside potential.

The Nifty Pharma index was trading 1.74 per cent up at 21830.45.